Superworth

AtriCure price to free cash flow ATRC

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Oct 23, 2026
56.5×
Peer median
26.2×

AtriCure's price to free cash flow is 56.5× as of Oct 23, 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 26.2×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far56.5×24.8×62.5×
202560.8×48.3×153×

Against its peers

Companies in Medical - Instruments & Supplies nearest AtriCure's size, closest first, today.

CompanyPrice to free cash flow
ATRCAtriCure56.5×
WRBYWarby Parker147×
NVSTEnvista15.3×
UFPTUFP Technologiesn/m
ICUIICU Medical27.3×
INSPInspire Medical Systems17.6×
BMIBadger Meter29.2×
VNTVontier12.1×
LMATLemaitre Vascular26.2×
HAEHaemonetics18.5×
MMSIMerit Medical Systems27.4×
Peer median26.2×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on AtriCure

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.